Glial cell line-derived neurotrophic factor (
GDNF) is important for the development and maintenance of dopamine neurons (Lin et al. [1993] Science 260: 1130-1132).
GDNF is neuroprotective in animal models of
Parkinson disease, where dopamine neurons show selective degeneration. We previously reported
GDNF-induced SPHK1 gene expression in a
neuroblastoma cell line, TGW (Murakami et al. [2007] J Neurochem 102: 1585-1594). In the present study, we focused on the regulatory mechanism of GAP43 (
GDNF-induced neuronal phenotype) transcription to further elucidate physiological roles of
GDNF-induced SPHK1 expression and activity. Stable wild-type (SPHK1-WT) but not dominant-negative SPHK1 (SPHK1-DN) overexpression increased both control- and
GDNF-induced GAP43 expression. SPHK1-WT cells showed enhanced
GDNF-induced
sphingosine 1-phosphate (S1P) secretion compared with mock- and SPHK1-DN cells. Exogenous S1P also increased GAP43 expression. In TGW cells,
PD98059, a
MEK inhibitor, but not
SB203580 (a
p38 MAPK inhibitor) and
LY294002 (a PI3K inhibitor) inhibited
GDNF-induced GAP43 expression, suggesting the MEK/ERK pathway has a major role in
GDNF-induced GAP43 transcription. A
G-protein-coupled receptor inhibitor,
pertussis toxin, and S1P(1) and S1P(3) receptor antagonists (
VPC23019 and
CAY10444) also inhibited ERK activation. Moreover, both S1P1 and S1P3 were
serine-phosphorylated by
GDNF, suggesting their activated states. C/EBPβ
transcription factor was induced by
GDNF, and
DNA pull-down and
chromatin immunoprecipitation assays revealed the C/EBP binding site between -131 bp and -98 bp from the first exon of GAP43. Taken together, our results showed that in TGW cells,
GDNF increased SPHK1 transcription, leading to the production and secretion of S1P. Through MEK/ERK pathway, S1P stimulates GAP43 transcription with increased binding of C/EBPβ to the 5'-promoter.